AcrySof ReSTOR to hit US shelves
Alcon has received FDA approval for the AcrySof ReSTOR intraocular lens (IOL) for the correction of aphakia following cataract surgery in patients with or without presbyopia.
Alcon has received FDA approval for the AcrySof ReSTOR intraocular lens (IOL) for the correction of aphakia following cataract surgery in patients with or without presbyopia.
The apodized, diffractive aspheric IOL is the only FDA approved presbyopia-correcting lens that incorporates aspheric optics into its design.
Alcon will commence a phased launch of AcrySof ReSTOR after necessary consignment quantities are established, with full distribution expected by the middle of the year.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
